Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | NLRP3 | Q96P20 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.35 |
| ▸ | TAB1 | Q15750 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30989822 | 0.90 | RIPK1 (0.42) | RIPK1HTTMEN1KMT2AATM | |
| SCHEMBL30989781 | 0.88 | RIPK1 (0.46) | RIPK1MEN1KMT2AATMNLRP3 | |
| SCHEMBL30989942 | 0.85 | RIPK1 (0.45) | RIPK1HTTMEN1KMT2AATM | |
| SCHEMBL30989972 | 0.83 | ALDH1A1 (0.49) | RIPK1HTTMEN1KMT2AALDH1A1 | |
| SCHEMBL30989876 | 0.82 | RIPK1 (0.48) | RIPK1MEN1KMT2AATMNLRP3 | |
| SCHEMBL30989882 | 0.79 | MEN1 (0.48) | RIPK1MEN1KMT2AATMNLRP3 | |
| SCHEMBL30989973 | 0.78 | RIPK1 (0.44) | RIPK1MEN1KMT2AATMNLRP3 | |
| SCHEMBL30989967 | 0.78 | RIPK1 (0.44) | RIPK1MEN1KMT2AATMNLRP3 | |
| SCHEMBL30989763 | 0.77 | RIPK1 (0.36) | RIPK1KMT2AALDH1A1 | |
| SCHEMBL30989925 | 0.76 | RIPK1 (0.42) | RIPK1HTTNLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612131-A1 | NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY | Cerevance, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024095003-A1 | NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY | Cerevance, Inc. (US) | 2024-05-10 | — | — | WO | disclosed |